Trials / Unknown
UnknownNCT04777422
Defibrotide in Children With High Risk Kawasaki Disease
A Pilot Study to Determine the Safety of Defibrotide in Children With High Risk Kawasaki Disease
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- New York Medical College · Academic / Other
- Sex
- All
- Age
- 0 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the safety of defibrotide with IVIG in children with high risk Kawasaki disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Defibrotide | Defibrotide 6.25 mg/kg IV q6h up to 7 days |
Timeline
- Start date
- 2021-02-24
- Primary completion
- 2023-10-24
- Completion
- 2024-06-01
- First posted
- 2021-03-02
- Last updated
- 2023-10-26
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04777422. Inclusion in this directory is not an endorsement.